TS
Tristel PLC
TSNLF · OTC
$5.74 +0.00% (+$0.00)
Market Cap £203.9M
P/E Ratio 30.71x
Div. Yield 3.28%
ROE 20.37%
Bulios Fair Price
$5.95
3.7% upside
Current Price
$5.74
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TSNLF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
37 /100
Fair P/E 30.71x
PEG 13.20x
EV/EBITDA 17.53x
Growth
85 /100
Growing Rev. growth 14.29%
Book val. growth 4.42%
FCF growth 29.55%
Profitability
90 /100
Strong Gross margin 81.65%
FCF margin 20.36%
Net margin 14.29%
Quality
89 /100
Excellent ROIC 16.25%
Asset turnover 1.02x
ROE 20.37%
Debt
100 /100
Low Debt/Equity 0.18x
Net debt/EBITDA -0.24x
Current ratio 3.60x
Stability
47 /100
Moderate Beta 0.34x
Profitable years 3
Rev. volatility 3.07%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TSNLF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Christopher Paul Lee
Employees
267
Headquarters
Snailwell
Upcoming events
19 OCT
Earnings
Upcoming earnings report